- Home
- FLGC vs HOTH Comparison
FLGC vs HOTH Comparison
Compare FLGC & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- HOTH
- Stock Information
- Founded
- FLGC 2019
- HOTH 2017
- Country
- FLGC United States
- HOTH United States
- Employees
- FLGC N/A
- HOTH N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- FLGC Health Care
- HOTH Health Care
- Exchange
- FLGC Nasdaq
- HOTH Nasdaq
- Market Cap
- FLGC 15.9M
- HOTH 16.0M
- IPO Year
- FLGC 2021
- HOTH 2019
- Fundamental
- Price
- FLGC $0.69
- HOTH $1.44
- Analyst Decision
- FLGC Buy
- HOTH Strong Buy
- Analyst Count
- FLGC 2
- HOTH 3
- Target Price
- FLGC $4.00
- HOTH $4.00
- AVG Volume (30 Days)
- FLGC 104.1K
- HOTH 745.9K
- Earning Date
- FLGC 08-11-2025
- HOTH 05-12-2025
- Dividend Yield
- FLGC N/A
- HOTH N/A
- EPS Growth
- FLGC N/A
- HOTH N/A
- EPS
- FLGC N/A
- HOTH N/A
- Revenue
- FLGC $53,260,000.00
- HOTH N/A
- Revenue This Year
- FLGC N/A
- HOTH N/A
- Revenue Next Year
- FLGC N/A
- HOTH N/A
- P/E Ratio
- FLGC N/A
- HOTH N/A
- Revenue Growth
- FLGC N/A
- HOTH N/A
- 52 Week Low
- FLGC $0.42
- HOTH $0.58
- 52 Week High
- FLGC $2.11
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- FLGC 55.93
- HOTH 62.68
- Support Level
- FLGC $0.62
- HOTH $1.17
- Resistance Level
- FLGC $0.72
- HOTH $1.34
- Average True Range (ATR)
- FLGC 0.05
- HOTH 0.10
- MACD
- FLGC 0.00
- HOTH 0.02
- Stochastic Oscillator
- FLGC 75.00
- HOTH 77.27
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).